Medtronic Remainder of 2026 decreased by 52.1% to $405.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $414.00M to $405.00M.
other_finite_lived_intangible_assets_amortization_expens_6aa235| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.29B | $862.00M | $430.00M | $1.26B | $839.00M | $421.00M | $1.26B | $836.00M | $419.00M | $1.23B | $824.00M | $414.00M | $1.30B | $846.00M | $405.00M |
| QoQ Change | — | -33.0% | -50.1% | +193.3% | -33.5% | -49.8% | +198.3% | -33.4% | -49.9% | +192.8% | -32.8% | -49.8% | +214.7% | -35.1% | -52.1% |
| YoY Change | — | — | — | -1.9% | -2.7% | -2.1% | -0.4% | -0.4% | -0.5% | -2.3% | -1.4% | -1.2% | +6.2% | +2.7% | -2.2% |